首页   >   新闻   >   文章

彭博推送 | 世界流行病回顾,华为 Mate 60 未在美销售
- 2023 -
12/01
23:15
零号员工
发表时间:2023.12.01     作者:Jingyi     来源:ShoelessCai     阅读:232

Children and their parents wait at a hospital in Beijing on Nov. 23. Photographer: JADE GAO/AFP


彭博推送 | 世界流行病回顾,华为 Mate 60 未在美销售。题目由 ShoelessCai 重新拟定。

本文由百度翻译完成翻译工作。

outbreaks of mycoplasma pneumoniae 肺炎支原体爆发
pathogens 病原体
rhinovirus 鼻病毒
mycoplasma 支原体
macrolides 大环内酯类
subdued 征服
In a nutshell 简而言之
ebbing 衰退
wary about 警惕
buck the larger trend 逆势而上
technological prowess to succeed 成功的技术能力
choke off supplies 阻断供应流

Deal with the hidden ... whatever! :)



Process of working, in Chinese!



01 译文

您好,我是 Allen Wan, 坐标上海。

去年11月,我报道了这座城市针对新冠肺炎清零的大规模抗议活动,快进到现在,今年圣诞节我只想让地铁乘客戴上口罩,因为肺炎支原体或“行走性肺炎”的爆发成为中国最新的健康恐慌,引起了全世界的关注。

又一波支原体病毒

当被世界卫生组织问及儿童中广泛聚集性未确诊肺炎的报告时,卫生当局表示,患病人数的增加是由于流感、鼻病毒、呼吸道合胞病毒和支原体等已知病原体。

他们说,还没有发现新的细菌。到目前为止,还没有死亡报告。

中国的甲流严重,北京某医院表示,病床非常紧张。

事实是,支原体并不罕见。它是一种常见的病原体,会导致五岁或五岁以上儿童患肺炎,每两年到四年在中国引发一次流行病。

虽然它往往只会导致年龄较大的儿童和免疫系统强大的成年人患轻度感冒,但年龄较小的儿童容易患上肺炎,这让人们担心一旦感染该怎么办。支原体对一种名为大环内酯类的抗生素具有耐药性。高达80%的儿童对常用的阿奇霉素和类似药物没有反应。

美国和欧洲大部分地区正在应对流感和呼吸道合胞病毒。一项研究表明,在新冠肺炎疫情防控措施解除后的近两年里,中国的支原体得到了抑制。


Children and their parents wait at a hospital in Beijing on Nov. 23. Photographer: JADE GAO/AFP


这就引出了一个问题:为什么世界的注意力都集中在中国,而非其他遭遇流感的国家?

彭博社观点专栏作家 F.D.弗拉姆 指出,简而言之,中国始终受到挑战。

在此次疫情期间,中国卫生部 敦促地方当局增加发热门诊的数量。国务院的特别工作组,通知地方政府通过在边境进行体温检测,以及加强对学校和疗养院的管理,以此为疫情做好准备。

然而,这些措施的作用,还或未可知。卫生当局表示,即使儿童支原体肺炎的激增显示出消退的迹象。这个没有新冠肺炎限制的第一个冬天,其他呼吸道疾病也可能对更广泛的人群造成沉重打击,也不免让人担忧。与此同时, 在地铁和拥堵地区戴口罩肯定会有所帮助 。针对这一问题,公众的态度保持谨慎。

美国商务部与中国企业

5年前,美国商务部权限限制华为在美的产品销售。如今华为 MATE 60 尚未在美国出售,原因不详。有意思的是,这款手机居然号称“在国外被枪疯了”。与华为合作的科技公司的股价都大幅上涨。点击《 门店大排长龙,华为Mate60为何不对海外市场出售? 》获取详细信息。

业界有传言称,华为进驻芯片行业,受到行业内外、各界人士的关注。


A teardown conducted for Bloomberg News found most components in the Mate 60 were made in China.


虽然华为始终划清清晰的边界,然而,华为去年仍然进军了半导体行业(该公司在武汉开设了芯片工厂)。然而,作为国内通信行业巨头,其成为国内行业领军,似乎也是在期望之中

彭博社称,华为受美国制裁越来越多。这几年,多次向光学专家、芯片设备开发商、化学品制造商等组织提供资金和工程专业知识,但没有披露其参与情况。

事实是,标普全球评级分析师 Clifford Kurz 表示,关键是创造出国内替代品,足以应对美国商务部各种“卡脖子”问题

华为对于其开发芯片技术,表示 始终保持独立


WATCH: When Huawei shocked America with a smartphone


“华为现在是中心”北京咨询公司 Trivium China 的合伙人 Kendra Schaefer 说。“出口管制以前所未有的方式推动了团结。”

华为将其新智能手机的发布时间安排在美国商务部长 吉娜·雷蒙多 访问中国的同时。

02 原文

Last November, I was covering the massive street protests against Covid Zero in this city and wondered along with the demonstrators if the lockdowns, mass testing and mask wearing would ever end.

Fast forward to now and all I want for this Christmas is for subway riders to be required to put on masks as outbreaks of mycoplasma pneumoniae, or “walking pneumonia” become the latest health scare out of China to capture.

The Chinese government is saying there is nothing major to worry about. When asked by the World Health Organization about reports of widespread clusters of undiagnosed pneumonia in children, health authorities said the uptick in sick people was due to known pathogens such as influenza, rhinovirus, RSV and mycoplasma.

No new germs have been found, they said. And so far, no deaths have been reported.

That's probably little comfort to parents who have had to wait several hours in hospitals in Beijing and other cities in the north for their sick children to see a doctor. The scenes of overcrowded hallways and children on intravenous infusions have brought back memories of the early days of Covid, which emerged as a mysterious pneumonia.

The truth is, mycoplasma is not unusual. It is a common pathogen that causes pneumonia among children aged five or above, and it has triggered epidemics in China every two-to-four years.

While it tends to cause only mild colds in older kids and adults with robust immune systems, younger children are prone to develop pneumonia — creating concern on what to do once they get it. China has the world’s highest incidence of mycoplasma that’s resistant to a class of antibiotic called macrolides. Up to 80% of cases in kids don’t respond to the commonly prescribed azithromycin and similar drugs.

Oddly, China appears to be the only country facing a major mycoplasma outbreak. The US and much of Europe are dealing with the flu and RSV. One study showed mycoplasma was subdued in China for almost two years by Covid countermeasures that have since been lifted.

So that begs the question: Why is the world's attention focused on China, when other countries have experienced similar surges in respiratory disease after dropping pandemic restrictions?

In a nutshell, Beijing is suffering from a trust deficit, Bloomberg Opinion columnist F.D. Flam points out.

After stonewalling on the deadly SARS outbreak many years earlier, the Chinese government showed during the Covid pandemic its inability to be transparent on issues of global concern. It was slow to warn the world about the dangers of that disease, while possibly destroying evidence about the virus’ origins.

Chinese authorities may finally be learning from their past mistakes. During this current outbreak, the health ministry urged local authorities to increase the number of fever clinics. A State Council taskforce ordered local governments to be better prepared for outbreaks by using temperature checks at borders and stronger management of schools and nursing homes.

These measures, though, may fall short in the months ahead. Health authorities say that even with the surge in mycoplasma-caused pneumonia in children showing signs of ebbing, other respiratory illnesses are likely to hit the broader population hard during the mainland’s first winter without Covid restrictions.

In the meantime, wearing a mask on the subway and in congested areas would certainly help. It’s just a question of whether a public wary about any hint of measures that evoke pandemic restrictions will want to take that step.

National Champion

Huawei has come back to life.

Less than five years after US sanctions nearly crippled the Chinese technology giant, its Mate 60 smartphone — powered by a homegrown high-tech semiconductor — is flying off the shelves and hurting Apple iPhone sales in China.

That success is helping Huawei’s business partners buck the larger trend of a terrible year for equities in China. Firms that work with the tech company have enjoyed massive stock gains.

Huawei's change of fortunes can be traced back to Beijing’s moves to counter Washington’s efforts to limit China’s development of next-generation tech.

While Huawei founder Ren Zhengfei has in the past said his private company had no special standpoint, that seems to have shifted in recent years.

REMARK: bold words has been changed by ShoelessCai.com

It is said that Huawei had invested around $30 billion to help it build chip fabrication facilities. Huawei moved into semiconductor production last year, and Huawei would also help smaller firms in strategic areas of the chip supply chain.

In effect, Huawei had been the key effort to develop a self-sufficient chip industry, people familiar with the matter said. It’s the rare national champion with the grit, scale and technological prowess to succeed.

Bloomberg News found that the US-sanctioned firm is increasingly funding and lending engineering expertise to a group that includes optical specialists, chip equipment developers and chemical manufacturers, without disclosing its involvement.

The truth is Beijing doesn't have to establish self-sufficiency at each step of the supply chain. The key is to create domestic alternatives at four or five steps of the process where the US and its allies can choke off supplies, said Clifford Kurz, an analyst with S&P Global Ratings.

“Huawei is now the centerpoint,” said Kendra Schaefer, a partner at Beijing-based consultancy Trivium China. “The export controls have pushed the state and industry together in a way we haven't seen before.”

Huawei poses its unique set of challenges, including pressure to get involved in gamesmanship between US and China. Huawei timed the release of its new smartphone to coincide with US Commerce Secretary Gina Raimondo's visit to China in part because of direct encouragement from a senior official at the top of the regime, according to a person familiar with the situation.

It was time to show some muscle, the person said.

Huawei denied that they had changed plan for the Mate 60 phone to be introduced.



原文链接



长按/扫码,有您的支持,我们会更加努力!









TOP 5 精选

       



回到顶部   回上一级
写文章

最新资讯




直播笔记


热点话题


精品论文


有你的鼓励
ShoelessCai 将更努力





文档免费。保护知识产权,保护创新。